Financhill
Back

RxSight Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
23

RXST
RxSight

Last Price:
$24.84
Seasonality Move:
36.09%
Sell
48

SRPT
Sarepta Therapeutics

Last Price:
$74.08
Seasonality Move:
14.66%
Sell
23
RxSight (RXST) is a Sell

Is RxSight a Buy, Sell or Hold?

  • The current RxSight [RXST] share price is $24.84. The Score for RXST is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • RXST is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $74.10. The Score for SRPT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RXST Stock Price Chart

What is RxSight's stock price today?

  • The RxSight share price today is $24.84
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RXST is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $74.10
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

RXST Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.68 Sell
Relative Strength Index (14 RSI): 31.92 Sell
Chaikin Money Flow: 548495 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.3 - 29.92) Sell
Bollinger Bands (100): (28.55 - 44.89) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -8.7 Sell
Relative Strength Index (14 RSI): 27.9 Sell
Chaikin Money Flow: -367389 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (88.59 - 111.17) Sell
Bollinger Bands (100): (103.29 - 127.87) Sell

RXST Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.49 Sell
20-day SMA: 26.75 Sell
50-day SMA: 30.12 Sell
200-day SMA: 44.52 Sell
8-day EMA: 25.44 Sell
20-day EMA: 26.84 Sell
50-day EMA: 30.3 Sell
200-day EMA: 39.85 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 87.22 Sell
20-day SMA: 97.87 Sell
50-day SMA: 108.64 Sell
200-day SMA: 125.16 Sell
8-day EMA: 84.58 Sell
20-day EMA: 94.74 Sell
50-day EMA: 105.16 Sell
200-day EMA: 118.38 Sell

RxSight Earnings Growth & RXST Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.00 per share, an increase this year of $0.04 per share, and an increase next year of $0.36 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.64 per share, an increase this year of $5.33 per share, and an increase next year of $5.23 per share.

RxSight Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):